FABP4 and colorectal carcinoma: Individuals in the highest compared to the lowest FABP‐4 quartile had a 1.49‐fold higher risk of CRC‐specific death (95% CI: 1.11–2.00; p‐trend = .01) and a similar higher risk of all‐cause death.